Leo Pharma eczema drug makes Express Scripts preferred product list

Express Scripts, the biggest pharmacy benefit manager (PBM) in the US, has made Leo Pharma’s Adbry one of its preferred products, putting the Danish atopic eczema treatment at the same level as its blockbuster competition, Sanofi’s Dupixent.
Leo Pharma's Adbry is now listed as one of the preferred products of Express Scripts, the biggest PDM in the US.
Leo Pharma's Adbry is now listed as one of the preferred products of Express Scripts, the biggest PDM in the US.
by ulrich quistgaard, translated by daniel pedersen

Leo Pharma’s atopic eczema drug, Adbry (tralokinumab), is now on the list of preferred drugs at Express Scripts, which is the biggest pharmacy benefit manager (PBM) in the US with 22 million customers across 50 states.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading